Heart rate

Amazfit to Launch Bip 3 Series of Smartwatches in Malaysia from 15 June

Retrieved on: 
Wednesday, June 15, 2022
System, Heart rate, US, Health, Technology, LCD, BIP, Zepp, Satellite, Life, Online shopping, Television, Amazfit

The Bip 3 will be launched online on 15 June while the Bip 3 Pro is available for pre-orders until 25 June, when it is launched online.

Key Points: 
  • The Bip 3 will be launched online on 15 June while the Bip 3 Pro is available for pre-orders until 25 June, when it is launched online.
  • Jacob Jin (Amazfit SEA Director) Amazfit said, "Smartwatches in the US$25 to US$75 price category continues to grow globally.
  • The Bip series is one of the top selling smartwatches priced between US$39 and US$49 with advantages in ID, screen size and endurance.
  • To know more on the Bip 3 series of smartwatches, please go to www.amazfit.com/en or to Amazfit's e-commerce partner platform http://bit.ly/Amazfit-MY-SHOPEE.

Research Reveals Long COVID Symptoms Persist More Than A Year After Onset, Spotlights Need For SSDI Benefits, Allsup Reports

Retrieved on: 
Tuesday, June 14, 2022
PDF, Infection, Coronavirus, Time, Headache, Insurance, COVID, SSDI, Disability, Social Security Administration, Fatigue, Social Security Disability Insurance, Medicare, Geist, First Time, Record, Dizziness, Symptoms of COVID-19, Smell, Heart rate, Annals of Clinical Biochemistry, SSA, Brain, Social Security, GLOBE, Patient, COVID-19, Research, Quality of life, Diagnosis, Population, American Veterans Disabled for Life Memorial, Blood pressure, Neurology, Social, Health insurance, Pharmaceutical industry, Northwestern Medicine

Allsup, which provides SSDI and veterans disability appeal services, has documented an increase in SSDI claims related to COVID-19 since the start of the pandemic.

Key Points: 
  • Allsup, which provides SSDI and veterans disability appeal services, has documented an increase in SSDI claims related to COVID-19 since the start of the pandemic.
  • Loss of taste and smell decreased over time, but heart rate and blood pressure variation and gastrointestinal symptoms increased.
  • Researchers estimate that long COVID may affect up to 30% or an estimated 24 million people in the U.S.
  • Allsup has helped more than 350,000 individuals with disabilities obtain SSDI benefits for over 38 years, Geist said.

Impulse Dynamics Announces First International Implants of the Optimizer Smart Mini System in Italy

Retrieved on: 
Tuesday, June 14, 2022
Cardiac muscle, Research, CCM, Marketing, Impulse, LinkedIn, Forward-looking statement, Ospedale del Ceppo, Mathematical optimization, Hope, Â, Heart failure, Heart rate, Physician, FDA, GLOBE, Patient, Technology, Quality of life, Twitter, MD, Population, Industry, Certification, Heart, Cardiology, Blood, Safety, Medical device, Facebook

Dr. Stefano Guarracini, Head of Cardiology at the Synergo Casa di Cura Pierangeli Hospital in Pescara, Italy, described his experience with CCM therapy and his outlook for the Optimizer Smart Mini system after the first implant.

Key Points: 
  • Dr. Stefano Guarracini, Head of Cardiology at the Synergo Casa di Cura Pierangeli Hospital in Pescara, Italy, described his experience with CCM therapy and his outlook for the Optimizer Smart Mini system after the first implant.
  • Starting in 2019, we had the opportunity to implant Optimizer devices in several patients with heart failure.
  • We believe in the technology and consider CCM therapy to be the only option for many patients suffering from heart failure.
  • We believe that the launch of the Optimizer Smart Mini system is an example of the importance of a global infrastructure to support ongoing technology innovation and access.

Not One Miracle, But Two: St. Elizabeth Healthcare Teams Collaborate to Save Mother and Baby

Retrieved on: 
Friday, June 10, 2022
Life, Emergency medicine, Vital signs, Neonatal intensive care unit, Emergency department, Trauma, Nursing, ER, Heart rate, Level, Cath lab, Memory, Bed, Intensive care unit, Obstetrics, Heart, ICU, Family, EKG, NICU, Hospital, Medicine

EDGEWOOD, Ky., June 10, 2022 /PRNewswire/ -- Veronica and Sean Williams could not have imagined the events following a high heart rate alert from Veronica's health watch. After mom-to-be and her partner notified their obstetrics care team via MyChart, it was recommended that they visit the Emergency Room (ER) for what they assumed would be a quick checkup. Little did they know, Sean would later be forced to answer the unimaginable question, "If we can only save one of them, mom or baby, who do you want us to save?"

Key Points: 
  • As Veronica fought for her life, her heart completely stopping at times, more than six different St. Elizabeth teams acted swiftly to keep both mom and baby alive.
  • St. Elizabeth nurses noted this was the first-ever Cath Lab delivery in St. Elizabeth historyand hopefully, the last.
  • Unsure if Veronica would ever have the chance to meet her baby, a touching decision was made by the St. Elizabeth teams.
  • The life-saving efforts from healthcare professionals reflected the multidisciplinary approach to care at St. Elizabeth, spanning across seven units including:

Advanced Baby Monitor Market Forecast Report 2021: USD 385.42 Million Market Growth Opportunity by 2025 | Technavio

Retrieved on: 
Friday, June 10, 2022
Woman, SIDS, ISO 9001:2015, Market share, Sudden infant death syndrome, Temperature, Electronics, MEA, Awareness, Heart rate, Growth, ASR, ISO, Technology, Lists of countries and territories, Adoption, Movement, Parent, Analysis, Certification, Skin, CAGR, Research report, Toy, Geography

With ISO 9001:2015 certification, Technavio is proudly partnering with more than 100 Fortune 500 companies for over 16 years.The advanced baby monitor market sizeis expected to increase by USD385.42 million from 2020 to 2025,and the market's growth momentum will accelerate at a CAGR of 10.42%.Technavio categorizes the global advanced baby monitor market as a part of the consumer electronics market.

Key Points: 
  • With ISO 9001:2015 certification, Technavio is proudly partnering with more than 100 Fortune 500 companies for over 16 years.The advanced baby monitor market sizeis expected to increase by USD385.42 million from 2020 to 2025,and the market's growth momentum will accelerate at a CAGR of 10.42%.Technavio categorizes the global advanced baby monitor market as a part of the consumer electronics market.
  • The key factors driving the advanced baby monitor market are the innovation in technology and product design and features leading to premiumization.
  • Lack of awareness and high price of advanced baby monitors will be a major challenge for the advanced baby monitor market during the forecast period.
  • The advanced baby monitor market is concentrated and the vendors are deploying growth strategies such asR&D and innovation like deploying sensor-driven technology to detect the movement of infantsto compete in the market.

Livindi Continues to Expand Award Winning Products to Help Older Adults Stay Safe, Healthy and Happy

Retrieved on: 
Wednesday, June 8, 2022
Seniors, Insurance, Pharmaceutical, General Health, Health, Mental Health, Professional Services, Consumer, Exercise, UnitedHealth Group, Caregiver, Medicine, Telehealth, Behavior, Depression, CEO, UNH, Multimedia, Heart rate, Patient, Pulse, Review, NYSE, Compliance, Thermoregulation, Blood pressure, Communication, Calendar, Mobile phone, Risk management, Residential care

Families, staff at homecare agencies and facilities can now also check medication adherence and start a video call to review compliance.

Key Points: 
  • Families, staff at homecare agencies and facilities can now also check medication adherence and start a video call to review compliance.
  • The personal reminder and group calendar module provides a new way to stay organized with all the important dates in one place!
  • With a regular and varied activity schedule older adults retain a strong sense of independence and stress levels decrease.
  • About Livindi: Livindi is an in-home connected care platform for seniors, caregivers, senior living providers and insurers to communicate, monitor, and deliver care services.

Carilion Clinic Partners with TytoCare to Expand Telehealth Offerings with Remote Physical Examinations

Retrieved on: 
Wednesday, June 8, 2022
Entrepreneurship, Carilion, Abdomen, ACO, CEO, Partnership, Algorithm, CE, Solution, Heart rate, Physician, Machine learning, FDA, Student, Patient, Hospital, Carilion Clinic, Diagnosis, NEW, Thermoregulation, Heart, Asthma, Skin, Accountable care organization, Medical device, Medicine

NEW YORK, June 8, 2022 /PRNewswire/ --  TytoCare, the global healthcare industry's first all-in-one modular device and examination solution for AI-powered, remote medical exams, is partnering with Carilion Clinic, a not-for-profit healthcare organization based in Roanoke, Virginia. The integration of TytoCare into Carilion's current virtual care offerings enhances the health system's ability to diagnose and treat patients remotely with in-depth, physical examinations during virtual visits.

Key Points: 
  • The integration of TytoCare into Carilion's current virtual care offerings enhances the health system's ability to diagnose and treat patients remotely with in-depth, physical examinations during virtual visits.
  • Rural communities comprise two-thirds of areas suffering from a shortage of primary care physicians in the United States.
  • Carilion provides quality care for nearly one million Virginians, many in rural communities, and through its partnership with TytoCare, Carilion will expand primary care access for its patients.
  • TytoCare is a telehealth company using AI to transform primary care by putting health in the hands of consumers.

PZU Zdrowie (Eng. PZU Health) rolls out Cardiomatics solution for precise diagnostics in cardiology across their clinics.

Retrieved on: 
Wednesday, June 8, 2022
Hungarian Central Statistical Office, Death, Insurance, Artificial intelligence, AI, Algorithm, City, Cardiology, Arrhythmia, GUS, Heart rate, MIT, Workflow, Patient, Kubicki, Technology, AF, Health, ANSI, Diagnosis, PZU, Prevalence, Population, Degenerative disease, ENG, ECG, Atrial fibrillation, Krishna River Management Board, HIPAA, Medical device

Polish company Cardiomatics has been fine-tuning the technology since 2018 and today is one of the leading suppliers of ECG analysis software.

Key Points: 
  • Polish company Cardiomatics has been fine-tuning the technology since 2018 and today is one of the leading suppliers of ECG analysis software.
  • That's why we want to further develop our tools for cardiac diagnostics," says Oliwer Kubicki, a member of PZU Zdrowie's Management Board.
  • "Cardiomatics and PZU Zdrowie share a common goal of using modern technologies to facilitate access to medical care.
  • It's a CE Class IIa medical device, and the effectiveness of its AI algorithms has been validated in clinical trials.

PZU Zdrowie (Eng. PZU Health) rolls out Cardiomatics solution for precise diagnostics in cardiology across their clinics.

Retrieved on: 
Wednesday, June 8, 2022
Hungarian Central Statistical Office, Death, Insurance, Artificial intelligence, AI, Algorithm, City, Cardiology, Arrhythmia, GUS, Heart rate, MIT, Workflow, Patient, Kubicki, Technology, AF, Health, ANSI, Diagnosis, PZU, Prevalence, Population, Degenerative disease, ENG, ECG, Atrial fibrillation, Krishna River Management Board, HIPAA, Medical device

Polish company Cardiomatics has been fine-tuning the technology since 2018 and today is one of the leading suppliers of ECG analysis software.

Key Points: 
  • Polish company Cardiomatics has been fine-tuning the technology since 2018 and today is one of the leading suppliers of ECG analysis software.
  • That's why we want to further develop our tools for cardiac diagnostics," says Oliwer Kubicki, a member of PZU Zdrowie's Management Board.
  • "Cardiomatics and PZU Zdrowie share a common goal of using modern technologies to facilitate access to medical care.
  • It's a CE Class IIa medical device, and the effectiveness of its AI algorithms has been validated in clinical trials.

Prapela's promising treatment for opioid-exposed babies submitted to FDA

Retrieved on: 
Tuesday, June 7, 2022
Apnea, Caregiver, NIDA, De novo, Tremor, Caffeine, National Institute on Drug Abuse, Neuron, CEO, Medtech, Organization, Heart rate, Sale, FDA, Transitive dependency, Hospital, Technology, Review, Parent, Physician, Pregnancy, Vibration, Irritability, National Institute, Pharmaceutical industry

BIDDEFORD, Maine, June 7, 2022 /PRNewswire/ -- Prapela, Inc. has submitted its unique bassinet pad for FDA clearance as a complementary treatment for newborns suffering from opioid withdrawal. Approval would make Prapela's product the first available medical device to treat newborns diagnosed with neonatal opioid withdrawal syndrome (NOWS).

Key Points: 
  • Submission to the FDA is a significant milestone for Prapela and improving the treatment of opioid-exposed newborns in hospitals and specialty centers.
  • has submitted its unique bassinet pad for FDA clearance as a complementary treatment for newborns suffering from opioid withdrawal.
  • Approval would make Prapela's product the first available medical device to treat newborns diagnosed with neonatal opioid withdrawal syndrome (NOWS).
  • Prapela submits promising drug-free treatment for opioid-exposed newborns to FDA for clearance.